Raymond Debbane - Net Worth and Insider Trading
Raymond Debbane Net Worth
The estimated net worth of Raymond Debbane is at least $12 Million dollars as of 2024-05-11. Raymond Debbane is the Director of Lexicon Pharmaceuticals Inc and owns about 6,792,051 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $12 Million. Raymond Debbane is the Director of WW International Inc and owns about 126,432 shares of WW International Inc (WW) stock worth over $251,600. Raymond Debbane is also the Director of Ceres Inc and owns about 2,083 shares of Ceres Inc (CERE) stock worth over $21,455. Details can be seen in Raymond Debbane's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raymond Debbane has not made any transactions after 2023-10-12 and currently still holds the listed stock(s).
Transaction Summary of Raymond Debbane
Raymond Debbane Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raymond Debbane owns 6 companies in total, including WW International Inc (WW) , Lexicon Pharmaceuticals Inc (LXRX) , and Blue Buffalo Pet Products Inc (BUFF) among others .
Click here to see the complete history of Raymond Debbane’s form 4 insider trades.
Insider Ownership Summary of Raymond Debbane
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WW | WW International Inc | 2022-11-10 | director |
| LXRX | Lexicon Pharmaceuticals Inc | 2023-10-12 | director & 10 percent owner |
| BUFF | Blue Buffalo Pet Products Inc | 2018-04-24 | director |
 | | 2014-03-07 | director |
| | 2008-05-10 | 10 percent owner |
| | 2006-10-12 | 10 percent owner |
Raymond Debbane Latest Holdings Summary
Raymond Debbane currently owns a total of 3 stocks. Among these stocks, Raymond Debbane owns 6,792,051 shares of Lexicon Pharmaceuticals Inc (LXRX) as of October 12, 2023, with a value of $12 Million and a weighting of 97.8%. Raymond Debbane owns 126,432 shares of WW International Inc (WW) as of November 10, 2022, with a value of $251,600 and a weighting of 2.02%. Raymond Debbane also owns 2,083 shares of Ceres Inc (CERE) as of February 21, 2012, with a value of $21,455 and a weighting of 0.17%.
Latest Holdings of Raymond Debbane
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-10-12 | 6,792,051 | 1.79 | 12,157,771 |
| WW | WW International Inc | 2022-11-10 | 126,432 | 1.99 | 251,600 |
| CERE | Ceres Inc | 2012-02-21 | 2,083 | 10.30 | 21,455 |
Holding Weightings of Raymond Debbane
Raymond Debbane Form 4 Trading Tracker
According to the SEC Form 4 filings, Raymond Debbane has made a total of 4 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 1,000,000 shares on October 12, 2023, which cost Raymond Debbane around $1 Million.
According to the SEC Form 4 filings, Raymond Debbane has made a total of 1 transactions in WW International Inc (WW) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in WW International Inc is the acquisition of 75,000 shares on November 10, 2022, which cost Raymond Debbane around $320,250.
According to the SEC Form 4 filings, Raymond Debbane has made a total of 0 transactions in Ceres Inc (CERE) over the past 5 years. The most-recent trade in Ceres Inc is the sale of 0 shares on February 21, 2012, which brought Raymond Debbane around $0.
Insider Trading History of Raymond Debbane
- 1
Raymond Debbane Trading Performance
GuruFocus tracks the stock performance after each of Raymond Debbane's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond Debbane is 42.53%. GuruFocus also compares Raymond Debbane's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond Debbane within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Raymond Debbane's insider trading performs compared to the benchmark.
Performance of Raymond Debbane
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.12 | | | | | |
| Relative Return to S&P 500(%) | 13.97 | | | | | |
Raymond Debbane Ownership Network
Raymond Debbane Owned Company Details
What does WW International Inc do?
Who are the key executives at WW International Inc?
Raymond Debbane is the director of WW International Inc. Other key executives at WW International Inc include General Counsel and Secretary Michael F Colosi , Corp Controller Prin Acct Off Nicole Haag , and Chief Technology Officer Pierre-olivier Latour .
WW International Inc (WW) Insider Trades Summary
Over the past 18 months, Raymond Debbane made no insider transaction in WW International Inc (WW). Other recent insider transactions involving WW International Inc (WW) include a net sale of 14,818,300 shares made by S.a. Westend , a net purchase of 63,935 shares made by Sima Sistani , and a net sale of 45,900 shares made by Michael F Colosi .
In summary, during the past 3 months, insiders sold 0 shares of WW International Inc (WW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,864,200 shares of WW International Inc (WW) were sold and 119,935 shares were bought by its insiders, resulting in a net sale of 14,744,265 shares.
WW International Inc (WW)'s detailed insider trading history can be found in Insider Trading Tracker table.
WW International Inc Insider Transactions
Raymond Debbane Mailing Address
Above is the net worth, insider trading, and ownership report for Raymond Debbane. You might contact Raymond Debbane via mailing address: C/o The Invus Group, Llc, 750 Lexington Avenue, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
